As a positive control, we used a previously reported glioma-initiating mouse NS cell line, IENS (Ink4a/ARF deletion, EGFRvIII overexpression) (Bachoo et al. 2002; Bruggeman et al. 2007). The gene discussed is CDKN2A; the disease is central nervous system cancer.